According to a recent LinkedIn post from CMR Surgical, the company’s team participated in the IAGES–ELSA 2026 meetings in Mumbai, held 13–15 February. The post highlights that CMR showcased its Versius surgical robot to surgeons from India and the broader Asia-Pacific region, with many reportedly trying the system hands-on for the first time.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post also notes engagement with existing Versius users, whose feedback was portrayed as reinforcing the system’s role in supporting clinical practice. For investors, this activity suggests CMR is actively cultivating surgeon adoption and brand visibility in key emerging markets, which could support procedure growth and system placements over time.
Increased exposure at regional surgical congresses may help CMR build a larger installed base and recurring revenue from instruments, consumables, and service. Given the importance of clinician buy-in in the capital equipment and medtech sectors, the described interactions with both new and existing users could be a leading indicator of demand for Versius in minimally invasive and robotic surgery across APAC.